Is there still a role for intravenous heparin in acute stroke? Yes

Archives of Neurology

Volumn 56, Issue 9, 1999, Pages 1159-1160

  Grau, Armin J ^a   Hacke, Werner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A; DANAPAROID; HEPARIN; NADROPARIN; PLACEBO; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RECURRENT DISEASE; SECONDARY PREVENTION; SHORT SURVEY; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ACUTE DISEASE; ANTICOAGULANTS; CEREBROVASCULAR DISORDERS; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; RANDOMIZED CONTROLLED TRIALS;

EID: 0032885562     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.9.1159     Document Type: Short Survey

References (8)

1. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for Healthcare Professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:1901-1914.
2. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: a randomized trial. Stroke. 1983;14:668-676.
3. Duke RJ, Bloch RF, Turpie AG, Trebilcock R, Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial. Ann Intern Med. 1986; 105:825-828.
4. Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med. 1995;333:1588-1593.
5. Hommel M, for the FISS bis Investigators Group. Fraxiparine in Ischaemic Stroke Study (FISS bis) [abstract]. Cerebrovasc Dis. 1998;8(suppl 4):64.
6. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA. 1998;279:1265-1272.
7. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.
8. Willig V, Pawelec D, Mau J, Höxter G, Hacke W. Heparin effects in the European Cooperative Acute Stroke Study [abstract]. Stroke. 1997;28:272.